خواص دارویی و گیاهی
%PDF-1.6
%
75 0 obj
>
endobj
81 0 obj
>/Filter/FlateDecode/ID[]/Index[75 8]/Info 74 0 R/Length 40/Prev 1891464/Root 76 0 R/Size 83/Type/XRef/W[1 2 0]>>stream
hbbd`b`*bb`Heb`LlLl
See Crinone® vaginal gel
See Lubion®
See Cyclogest® pessaries
See Gestone® solution for injection
See Lutigest®
داروی utrogestan 200mg
See Utrogestan® capsules
See Utrogestan® vaginal capsules
Acute porphyrias
; avoid in patients with a history of liver tumours; breast cancer (unless progestogens are being used in the management of this condition); genital cancer (unless progestogens are being used in the management of this condition); history during pregnancy of idiopathic jaundice; history during pregnancy of pemphigoid gestationis; history during pregnancy of severe pruritus; history of thromboembolism; incomplete miscarriage; missed miscarriage; severe arterial disease; thrombophlebitis; undiagnosed vaginal bleeding
Asthma; cardiac dysfunction; conditions that may worsen with fluid retention; diabetes (progestogens can decrease glucose tolerance—monitor patient closely); epilepsy; history of depression; hypertension; migraine; susceptibility to thromboembolism (particular caution with high dose)
With oral use
headache; menstrual cycle irregularities
With vaginal use
breast pain; drowsiness; gastrointestinal discomfort
With oral use
breast pain; constipation; diarrhoea; dizziness; drowsiness; jaundice cholestatic; skin reactions; vomiting
With oral use
depression; nausea
With intramuscular use
alopecia; breast changes; cervical abnormalities; depression; drowsiness; fever; hirsutism; insomnia; jaundice cholestatic; menstrual cycle irregularities; nausea; oedema; protein catabolism; skin reactions; weight increased
With rectal use
diarrhoea; flatulence
With vaginal use
leakage of the pessary base; menstrual cycle irregularities; vulvovaginal pain
Not known to be harmful.
Avoid—present in milk.
Avoid in hepatic impairment.
Avoid in active liver disease including disorders of hepatic excretion (e.g. Dublin-Johnson or Rotor Syndromes), infective hepatitis (until liver function returns to normal) and liver tumours.
Use with caution.
With oral use
Capsules should be taken at bedtime on an empty stomach.
With oral use
Patient counselling is advised for progesterone capsules (administration).
See Lubion®
See Lutigest®
See Utrogestan® vaginal capsules
With vaginal use
Progesterone pessaries are less suitable for prescribing.
There can be variation in the licensing of different medicines containing the same drug.
Forms available from special-order manufacturers include: solution for injection
Pessary, Solution for injection, Vaginal gel, Capsule
داروی utrogestan 200mg
Other drugs classified as progestogens
© NICE 2019. All rights reserved. Subject to Notice of rights.
UK Edition. Click here for US version.
Active substance(s): PROGESTERONE
PDF options: View Fullscreen Download PDF
+ Expand Transcript
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.داروی utrogestan 200mg
Medical Disclaimer
The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices.
Subscribe to Drugs.com newsletters for the latest medication news, alerts, new drug approvals and more.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated 1 July 2019), Cerner Multum™ (updated 1 July 2019), Wolters Kluwer™ (updated 29 June 2019) and others.
Third Party Advertising
We comply with the HONcode standard for trustworthy health information – verify here
Copyright © 2000-2019 Drugs.com. All rights reserved.
Utrogestan may be available in the countries listed below.
UK matches:
Progesterone is reported as an ingredient of Utrogestan in the following countries:
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.داروی utrogestan 200mg
Medical Disclaimer
The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices.
Subscribe to Drugs.com newsletters for the latest medication news, alerts, new drug approvals and more.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated 1 July 2019), Cerner Multum™ (updated 1 July 2019), Wolters Kluwer™ (updated 29 June 2019) and others.
Third Party Advertising
We comply with the HONcode standard for trustworthy health information – verify here
Copyright © 2000-2019 Drugs.com. All rights reserved.
[Article in Bulgarian]
Marinov B, Petkova S, Dukovski A, Georgiev G, Garnizov T, Manchev V, Kolarov G,
Iunakova M.
داروی utrogestan 200mg
Utrogestan is a modern progesterone, which shows maximal effectiveness with
minimal side effects. It is a natural progesterone in micronized form, which
makes it suitable for oral administration and vaginal application with same
effectiveness. The aim of our retrospective study was to evaluate the
therapeutical effects of Utrogestan in women with threatened abortion in the
first trimester. Our experience dated from about one year and a half. Sixty eight
women were treated for threatened abortion with a daily dose of 400 mg
Utrogestan. The treatment continued at least 14 days/average 21 days/. Utrogestan
was administered orally twice daily. The main indications were first or
consecutive threatened spontaneous abortion in first trimester. For the period of
time no side effects and subjective complaints were established except particular
cases of slight headache and dizziness after morning application. Sixty one of
the sixty eight women were dehospitalised with healthy pregnancy with no side
effects. In our experience we preferred to use the drug in women with lutein
insufficiency before pregnancy. We conclude that Utrogestan can be widely applied
in Obstetrics with the proper indications, such as threatened abortion in the
first trimester. The prophylactic treatment in women with slighter complaints
like dull pain and weight Utrogestan is applied one tablet twice daily. In graver
cases the starting dosage is two tablets two or three times daily.
External
Published: 5/2016
For further information, talk to your doctor or pharmacist.
داروی utrogestan 200mg
Copyright 0000 RAD-AR Council, Japan. All rights reserved.
%PDF-1.6
%
943 0 obj
>stream
_0r9FWƮ$~]r9KK~V~[+-gY1Wb[1P^}Z,ޟ.w6
[T(yCxIOd]Udu
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Search for terms
Since progesterone derivatives are useful in preventing preterm labor in cases of risk factors or previous preterm labor, we hypothesize that they will also show efficacy in pregnancy prolongation in women whose preterm labor was arrested following tocolytic treatment.
Patients diagnosed with arrested pre-term labor following tocolytics at 24-34 gestational weeks will be randomly allocated to receive either vaginal micronized progesterone 400 mg/day or no treatment.
This study has the potential to find a treatment to prevent preterm labor and thus to reduce neonatal morbidity and mortality.داروی utrogestan 200mg
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Inclusion Criteria:
Exclusion Criteria
Contraindication to ongoing pregnancy including:
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02430233
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Search for terms
داروی utrogestan 200mg
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Inclusion Criteria:
Exclusion Criteria:
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01523483
